
Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Sympatholytic
Introduction
Overview
Overview
A sympatholytic is a medication which inhibits the functioning of the sympathetic nervous system (SNS). They are used as antihypertensives.
They mainly comprise antiadrenergic agents, but also anticholinergics in the case of the nicotinic antagonist, since nicotinic receptors relay the signals of the SNS across the ganglia.
Antiadrenergic
Antiadrenergic
Antiadrenergic agents inhibit the signals of adrenaline and noradrenaline. They are mainly adrenergic antagonists, inhibiting adrenergic receptors, but there are exceptions: clonidine is an adrenergic agonist on the α2 receptor, since this receptor is located presynaptically to inhibit further release of adrenaline and noradrenaline.
Other ways of inhibiting adrenergic signaling is by catecholamine synthesis blocking, e.g. by methyltyrosine. Reserpine works by inhibiting transport into synaptic vesicles of noradrenaline by inhibiting the VMAT transporter.
In hypotension
Many antiadrenergic agents used as antihypertensives include:
- centrally acting:
- Clonidine (α2 agonist)
- Guanfacine (α2 agonist)
- Methyldopa (α2 agonist)
- Moxonidine (imidazoline receptor agonist)
- Rescinnamine (ACE inhibitor)
- Reserpine (VMAT inhibitor)
- Rilmenidine (imidazoline receptor agonist)
- ganglion-blocking
- Mecamylamine (α3β4 nicotinic receptor inhibitor)
- Trimethaphan (ganglion type receptor inhibitor)
- peripherally acting
- Prazosin (α1 antagonist)
- Guanethidine (Magnesium-ATPase inhibitor)
- Indoramin (α1 antagonist)
- Doxazosin (alpha blocker)
External links
External links
- Sympatholytics at the US National Library of Medicine Medical Subject Headings (MeSH)
- Template:Dorlands
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
